Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3INDUSTRY 1FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Leukemia 48Precursor Cell Lymphoblastic Leukemia-Lymphoma 40Lymphoma 40Myelodysplastic Syndromes 30Lymphoma, Non-Hodgkin 29Lymphoma, Large B-Cell, Diffuse 27Lymphoma, Follicular 27Leukemia, Myeloid, Acute 26Leukemia, Myeloid, Chronic-Phase 25Leukemia, Lymphocytic, Chronic, B-Cell 24Burkitt Lymphoma 24Leukemia, Myeloid, Accelerated Phase 23Lymphoma, Large-Cell, Immunoblastic 22Multiple Myeloma 20Hodgkin Disease 20Myeloproliferative Disorders 19Lymphoma, Mantle-Cell 18Lymphoma, B-Cell, Marginal Zone 18Graft vs Host Disease 18Blast Crisis 18Neoplasms, Plasma Cell 17Leukemia, Myelomonocytic, Chronic 16Dendritic Cell Sarcoma, Interdigitating 15Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 14Congenital Abnormalities 14Recurrence 13Anemia, Refractory, with Excess of Blasts 13Primary Myelofibrosis 12Myelodysplastic-Myeloproliferative Diseases 12Lymphoma, T-Cell, Cutaneous 10

Interventions

Docetaxel 171Radiotherapy 144Magnetic Resonance Spectroscopy 142Leuprolide 112Prednisone 108enzalutamide 102Radiosurgery 101Abiraterone Acetate 94Androgen Antagonists 91Goserelin 83bicalutamide 81gallium 68 PSMA-11 70Surveys and Questionnaires 63apalutamide 57Specimen Handling 56acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 55Radiation 47Gonadotropin-Releasing Hormone 45Standard of Care 44Biopsy 44Brachytherapy 42Radiotherapy, Intensity-Modulated 40Blood Specimen Collection 40darolutamide 39abiraterone 39cabazitaxel 35Exercise 35Carboplatin 33Pluvicto 32Triptorelin Pamoate 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Prostatic Neoplasms × Methylprednisolone × Clear all
NCT02887976 2020-07-22

Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201

GU Research Network, LLC

Phase 3 Completed
2 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT00003682 2016-06-23

Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer

UNICANCER

Phase 3 Terminated
160 enrolled
Genitourinary

Prostatic Neoplasms

NCT00541281 2009-10-27

Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase 2 Completed
150 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡